bpc 157 help with sleep BPC-157 Delayed 60c by InfiniWell BPC-157 Peptide: Mechanism of Action

The application time was either at 20 min after L-NAME administration (as early therapy) or at 48 h after L-NAME administration (as delayed therapy)

Sansone A, Di Dato C, de Angelis C, et al

The narrow therapeutic window means even modest degradation of the preservative compromises the entire solution

Contraindications and Warnings The use of methylene blue is contraindicated during pregnancy due to the potential risks of fetal harm

Cycling Protocols for Long-Term Use Extended peptide use requires cycling to prevent receptor desensitization, allow the body natural recovery periods, and reduce the theoretical risks associated with prolonged administration